Dolutegravir Teva

Medicinal product

(Invented) name

Dolutegravir Teva

Active substance (s)

Dolutegraviras

Strength

50 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AJ03, Dolutegravir

Marketing authorisation holder

Teva GmbH, Vokietija

Date of authorisation

2026-08-11

Date of renewal

Documents

6115_pakuotes lapelis_2026-08-11.docx

6115_Dolutegravir Teva.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/6373/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Dolutegraviras	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
121869	107977	1107977	dalomoji lizdinė plokštelė	N30×1		Receptinis	LT/1/26/6115/001	Netiekiama	-	-	No	-	-
121870	107978	1107978	dalomoji lizdinė plokštelė	N90×1		Receptinis	LT/1/26/6115/002	Netiekiama	-	-	No	-	-
121871	107979	1107979	buteliukas	N30		Receptinis	LT/1/26/6115/003	Netiekiama	-	-	No	-	-
121872	107980	1107980	buteliukas	N90		Receptinis	LT/1/26/6115/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-08-11	Registruotas